
A Justice Department letter defending the administration’s antitrust collusion inquiry into automakers who sided with California against the Trump administration in last year’s emissions-standards conflict has leaked ahead of an upcoming congressional inquiry into the administration’s politicization of federal law enforcement, reported Yahoo News.
The US House of Representatives is launching an inquiry into whether the administration weaponized the Justice Department to further its own political goals. Among the subjects of the inquiry is the antitrust investigation that was launched into four automakers who reached an independent agreement with California-emissions standards to build vehicles with fuel economy superior to that required by the Trump administration’s revised standards.
Last July, Ford, BMW, Volkswagen, and Honda announced they had reached a deal to adopt standards that were lower than Obama-era rules but higher than the Trump administration’s 2018 proposal.
In doing so, the automakers defied the Trump administration’s effort to strip California of the right to fight climate change by setting its own standards. Automakers fear years of legal battles over conflicting sets of standards and want to ensure certainty over the requirements they will face nationwide.
Full Content: Yahoo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas